Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Related Keywords

United States ,Vietnam ,Republic Of ,Mexico ,Thailand ,India ,South Korea ,Giovanna Chandler ,Stanleyc Erck ,Linkedin ,Vaccine Administration Errors ,National Institute Of Allergy ,Department Of Defense ,Prnewswire Novavax Inc ,Nasdaq ,Vaccination Program ,Department Of Health ,Nuclear Defense ,Serum Institute Of India ,Novavax Inc ,National Institutes Of Health ,Biomedical Advanced Research ,Human Services ,Development Authority ,Centers For Disease Control ,Exchange Commission ,Office Of The ,Chief Executive Officer ,Emergency Use Authorization ,Acute Allergic Reactions ,Disease Control ,Vaccine Effectiveness ,Adverse Events ,Vaccine Administration ,Vaccine Adverse Event Reporting System ,Multisystem Inflammatory Syndrome ,Fax Number ,Telephone Number ,Adjuvanted Fact Sheet ,Healthcare Providers Administering Vaccine ,Vaccine Providers ,Serum Institute ,Assistant Secretary ,Defense Joint Program Executive Office ,National Institute ,Infectious Diseases ,National Institutes ,Vaccine Efficacy Novavax Trial ,New England Journal ,Financial Condition ,Novavax Annual Report ,Quarterly Reports ,Novavax ,Nc ,